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Invasive candidiasis is a leading cause of nosocomial bloodstream infection. Neutrophils 
are the important effector cells in host resistance to candidiasis. To investigate the mod-
ulation of neutrophil fungicidal function will advance our knowledge on the control of 
candidiasis. While recombinant galectin-3 enhances neutrophil phagocytosis of Candida, 
we found that intracellular galectin-3 downregulates neutrophil fungicidal functions. 
Co-immunoprecipitation and immunofluorescence staining reveal that cytosolic gal3 
physically interacts with Syk in neutrophils after Candida stimulation. Gal3−/− neutrophils 
have higher level of Syk activation as well as greater abilities to generate reactive oxygen 
species (ROS) and kill Candida than gal3+/+ cells. While galectin-3 deficiency modulates 
neutrophil and macrophage activation and the recruitment of monocytes and dendritic 
cells, the deficiency does not affect the numbers of infiltrating neutrophils or macro-
phages. Galectin-3 deficiency ameliorates systemic candidiasis by reducing fungal bur-
den, renal pathology, and mortality. Adoptive transfer experiments demonstrate that cell 
intrinsic galectin-3 negatively regulates neutrophil effector functions against candidiasis. 
Reducing galectin-3 expression or activity by siRNA or gal3 inhibitor TD139 enhances 
human neutrophil ROS production. Mice treated with TD139 have enhanced ability to 
clear the fungus. Our work unravels the mechanism by which galectin-3 regulates Syk-
dependent neutrophil fungicidal functions and raises the possibility that blocking gal3 in 
neutrophils may be a promising therapeutic strategy for treating systemic candidiasis.
Keywords: galectin-3, Candida albicans, neutrophil, reactive oxygen species, syk kinase, TD139, M2 macrophage, 
monocyte/dendritic cell recruitment
inTrODUcTiOn
Galectin-3 (gal3) belongs to a family of evolutionarily highly conserved animal lectins. It is 
structurally unique amongst all the known galectins by consisting of a proline- and glycine-rich 
non-lectin domain in the N-terminal part, in addition to the C-terminal carbohydrate-recognition 
domains (CRD) (1). Gal3 binds to the N-acetyllactosamine motif of glycoproteins through its CRD 
and undergoes polymerization through its N-terminal part (1, 2). It is expressed in macrophages, 
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dendritic cells, activated lymphocytes, epithelial cells, and neu-
trophils and found in both intracellular and extracellular com-
partments as well as on the cell surface (3). Recombinant gal3 has 
been reported to function extracellularly as a chemoattractant, a 
pro-apoptosis mediator, an opsonizing molecule, a phagocytosis 
enhancer, and a mediator that bridges hyperglycosylated mucin 
MUC2 and dendritic cells (2). Cell intrinsic gal3 has also been 
reported to function intracellularly as an anti-apoptosis mediator 
and a regulator for T cell activation, keratinocyte migration, and 
phagocyte cellular responses (4–8). Intracellular gal3 modulates 
cellular responses and tumor cell apoptosis by direct association 
with internalized dectin-1 (9), signaling molecule (10), adaptor 
protein (11), or apoptosis regulator (12). Point mutation at the 
CRD abolishes gal3 binding to Bax, thereby interfering its anti-
apoptotic effect (12), showing that the CRD of gal3 is involved 
in interaction with proteins, but the interaction is carbohydrate 
independent.
Neutrophils express gal3 intracellularly although at lower lev-
els compared to other innate cells (3, 13). In vitro studies showed 
that gal3 added exogenously improves the ability of neutrophils 
to migrate, phagocytose, and produce IL-8 and reactive oxygen 
species (ROS) (13–15). Studies of the role of intracellular gal3 in 
neutrophil functions are limited. By comparing gal3−/− to gal3+/+ 
cells, gal3 is found to inhibit the neutrophil ROS response to 
phorbol myristate acetate or zymosan stimulation and regulate 
the life span of neutrophils upon Toxoplasma gondii infection (4). 
Thus, it appears that exogenously added gal3 and intrinsic gal3 
have distinct effects on neutrophils.
Candida albicans is a commensal organism colonizing human 
mucosal surface and the skin. The commensal organism grows 
as yeast and germinates to invade the host (16). Neutropenic 
patients or individuals with neutrophil dysfunction are at higher 
risk for invasive candidiasis (17–19). Invasive candidiasis affects 
more than 250,000 people each year and leads to more than 
50,000 deaths worldwide. Mortality among patients with invasive 
candidiasis can be as high as 40% even after receiving antifungal 
therapy (20). Study on candidemia cases revealed that time to ini-
tiate antifungal therapy has no impact on 30-day mortality (21), 
demonstrating that most patients do not respond to antifungal 
treatment. To develop better diagnostic biomarkers for patients 
with candidemia and better therapeutic strategy for disseminated 
candidiasis are important issues. In a mouse model of systemic 
candidiasis, Candida has marked tropism for kidney and brain 
(22). Mice with X-linked chronic granulomatous disease or with 
myeloperoxidase deficiency whose neutrophils are defective in 
producing ROS succumb to sublethal Candida infection (23). 
Depleting neutrophils exacerbates systemic candidiasis (24). 
These reports support the notion that neutrophils through pro-
ducing ROS are responsible for clearing Candida infection in both 
humans and mice. The animal model of systemic candidiasis is a 
powerful tool to investigate the function of neutrophils against 
Candida infection. Whether and how cell intrinsic gal3 regulates 
host defense against candidemia has never been addressed.
While most studies on the role of gal3 in Candida emphasize 
its extracellular functions, we uncover its intracellular role in 
modulating signaling pathways. Extracellular gal3 mostly sends 
outside-in signals to regulate cell activation, we show a direct 
regulation of Syk kinase by cytosolic gal3 in neutrophil response 
to Candida. Gal3 physically interacts with Syk and negatively 
regulates its activation. By applying cell-permeable gal3 inhibitor 
TD139 on human neutrophils or administering it to mice with 
systemic candidiasis, our work raises the possibility that blockade 
of gal3 in neutrophils may be a promising therapeutic strategy for 
systemic Candida infection.
MaTerials anD MeThODs
Fungus and infection
Candida albicans strain SC5314 (ATCC MYA-2876) and clinical 
isolates from patients with bloodstream infection (CL 10-1, CA 
09-1, CL 15-1, CA 01-1, CL 03-1, and CA 03-1, National Taiwan 
University Hospital) were used in this study. SC5314, clinical 
isolates, and GFP-expressing strain OG1 (25) were cultured at 
30°C on yeast–peptone–dextrose (YPD) agar (DIFCO) plate. 
Mice were injected intravenously with Candida yeasts prepared 
in RPMI 1640 medium. Candida yeasts were opsonized in phenol 
red free HBSS containing 10% fresh mouse or human serum at 
room temperature for 30 min.
Mouse neutrophil enrichment and 
adoptive Transfer
Bone marrow cells were harvested from the femurs and sus-
pended in dPBS buffer before overlaid on discontinuous percoll 
gradients (55, 62, and 81% in the order from top to bottom) (GE 
Healthcare). After centrifugation at 1,400 × g for 30 min, cells at 
the interface between 62 and 81% gradients were harvested and 
washed. Flow cytometric analysis showed that 92% of cells were 
CD11b+Ly6G+. For adoptive transfer, 5 × 106 neutrophils isolated 
from gal3+/+, gal3−/−, and littermate mice were injected into recipi-
ent mice through the tail vein. Recipient mice were given Candida 
intravenously 1 h later.
human neutrophil isolation
Fresh peripheral venous bloods were collected from healthy 
volunteers with no history of candidiasis in BD Vacutainer® Plus 
Plastic K2EDTA Tubes or serum separator tubes for different 
purposes. Neutrophils were isolated as described previously (26). 
Briefly, bloods were diluted in Mg2+- and Ca2+-free DPBS and 
overlaid on Ficoll-Paque solution (Ficoll-Paque™ PLUS, GE 
Healthcare). After centrifugation at 600 × g for 15 min, the pellet 
containing neutrophils and red blood cells (RBCs) was subject to 
dextran sedimentation (3%) to separate RBCs from neutrophils. 
Residual RBCs were lysed by lysis buffer. Cell viability was deter-
mined by trypan blue exclusion.
staining surface and cytosolic gal3
Neutrophils from human or mice were stimulated with opsonized 
Candida for 5 and 15 min. Cells were stained with rat anti-gal3 and 
fluorochrome-conjugated goat anti-rat antibodies. After fixation 
in 4% PFA and permeabilization in saponin (Sigma)-containing 
perm/wash buffer, cells were stained with Alexa 647-rat anti-gal3 
antibody. Samples were acquired by BD FACSCanto II and ana-
lyzed by BD FACSDiva software.
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renal infiltrating cell isolation and 
immunostaining
Kidneys were cut into small pieces and treated with 0.2 mg/
ml Liberase TM (Roche) at 37°C for 30  min. Pellets were 
resuspended in 45% percoll and overlaid on 81% percoll. Cells 
at the interface (45/81%) were collected after centrifugation. 
Cells stained positive for CD45 were taken as infiltrating 
cells. After exclusion of Ly6G+ neutrophils, cells were divided 
into three distinct populations according to the expression 
of MHC II and F4/80 (MHC II+F4/80+ as macrophages, 
MHC II−F4/80+ as monocytes, and MHC II+F4/80− as 
dendritic cells). Detailed description is given in Methods in 
Supplementary Material.
rOs Production
Bone marrow neutrophils were incubated in phenol red free 
HBSS containing 10 µM CM-H2DCFDA (Life Technologies) for 
30 min. After replenishment with fresh HBSS or with HBSS con-
taining kinase inhibitors, cells were stimulated with opsonized 
Candida yeasts (MOI =  0.5). Oxidative DCF was analyzed by 
flow cytometry. To assess ROS production by renal infiltrating 
neutrophils isolated from infected mice, neutrophils collected 
from percoll gradients were stained with CM-H2DCFDA and 
subject to flow cytometric analysis.
Human neutrophils were pretreated with mock (0.5% DMSO) 
or 250  μM of TD139 (3,3′-deoxy-3,3-bis(4-[m-fluorophenyl]-
1H-1,2,3-triazol-1-yl)-thio-digalactoside) (27) for 4  h before 
addition of CM-H2DCFDA. Cells were then stimulated by 
opsonized Candida for 20 min before subject to flow cytometric 
analysis.
Fungicidal activity assay
The assay was adopted from Methods in Molecular Biology (28). 
Briefly, Candida yeasts were grown in Sabouraud-dextrose broth 
(pH =  5.6) in 37°C overnight. Bone marrow neutrophils and 
CD45+Ly6G+ renal infiltrating cells were subject to killing assay 
in 96-well plate with 5 × 105 cells and 1 × 104 opsonized Candida 
yeasts. Wells containing opsonized Candida yeasts without 
neutrophils was used as control. Twenty minutes was allowed 
for phagocytosis after which supernatants in control wells and 
experimental groups were plated on YPD plate. The number of 
ingested yeasts (N0h) = the number of yeasts in control well − the 
number of uningested yeasts. The rest of the wells were incubated 
for another 1.5  h and the cells were lysed to release intracel-
lular yeasts. The lysates were plated. % Killing =  (N0h − N1.5h)/ 
N0h × 100%, where N = the number of intracellular Candida.
co-immunoprecipitation
Five million neutrophils were stimulated with opsonized 
Candida. Cells were lysed in 500 µl of non-denaturing lysis buffer. 
Cell lysates were mixed with 1.5 µg of mouse anti-gal3 antibody 
(B2C10) or 1 µg of anti-Syk polyclonal antibody at 4°C overnight. 
The mixture was mixed with 50 µl of agarose beads slurry under 
rotary agitation at 4°C for 4 h. Lysate beads mixture was washed 
with IP washing buffer. Beads were then mixed with 25  µl of 
sample buffer and boiled to elute immunoprecipitates.
Quantification of Fungal load
Kidney and brain were homogenized in a tissue grinder with 1 ml 
of RPMI 1640 medium. One to ten serial dilutions were made 
and 0.1 ml was plated on YPD agar. Colonies were counted after 
incubation at 30°C for 2 days.
Lgals3 gene Knockdown in human 
neutrophils
Three million human neutrophils were premixed with 
Nucleofector® Solution (Lonza) plus supplement in total volume 
of 100 µl followed by addition of 2 µM of scrambled siRNA or 
siRNA targeting gal3 (Santa Cruz Biotechnology). Cells were 
transfected by using Nucleofector® Program Y-001 in the nucleo-
fector II device and incubated in RPMI complete medium for 7 h 
before further experiment. Knockdown efficiency was about 47%. 
Cell viability was determined by trypan blue exclusion.
statistics
Mann–Whitney test (non-parametric analysis) was used to 
compare the difference between two groups. Mortality after 
Candida infection was analyzed by log-rank and Fisher’s exact 
test. Statistical significance was defined as p < 0.05.
ethics statement
Human study was approved by the Institutional Review Board 
of the National Taiwan University Hospital (Permit Number: 
201103121IRB, 201401074INA). All written informed consents 
were received from participants prior to inclusion in this 
study. Mouse study was carried out in strict accordance with 
the recommendations in the Guidebook for the Care and Use 
of Laboratory Animals, The Third Edition, 2007, published by 
The Chinese-Taipei Society of Laboratory Animal Sciences. The 
experimental protocol was approved by the Committee on the 
Ethics of Animal Experiments of the National Taiwan University 
College of Medicine (Permit Number: 20120031, 20130238, and 
20140304).
resUlTs
Dynamics of gal3 expression after 
neutrophils encountering Opsonized 
Candida
Previous studies revealed that recombinant gal3 positively 
regulates neutrophil functions when added exogenously, here we 
focused our study on the role of cell intrinsic gal3 in neutrophils. 
Fluorescence microscopic (Figure  1A) and flow cytometric 
analyses (Figures 1B,C) showed that above 80% of unstimulated 
neutrophils expressed low levels of gal3 in the cytosol and 
stimulation with opsonized Candida increased intracellular 
gal3 expression as early as 5 min after stimulation (Figure 1B). 
While dendritic cells and monocytes/macrophages constitutively 
express gal3 on the surface (29, 30), gal3 was not detected on 
the surface of unstimulated neutrophils (Figure 1C). Stimulation 
by Candida induced gal3 redistribution to the cell surface in 
about 20% of neutrophils (Figure 1C). It was noted that intracel-
lular gal3 was diffusely distributed (Figure 1D) and 70.0 ± 8.8% 
FigUre 2 | gal3 negatively regulates complement receptor 3 downstream reactive oxygen species (rOs)-dependent killing of Candida by 
neutrophils. Gal3+/+ (WT), gal3−/−, Itgam−/−, and gal3−/−Itgam−/− neutrophils were allowed to ingest opsonized Candida yeasts. (a) The level of ROS production 
shown as mean fluorescence intensity (MFI) of oxidized DCF fluorescence. Zero minutes represent the MFI of unstimulated control incubated in serum-containing 
medium. n = 7 pooled from two independent experiments in panel (a). (B) Twenty minutes was allowed for phagocytosis. The number of Candida (Ca) engulfed by 
neutrophils is shown as CFU. (c,D) The ability of neutrophils to kill opsonized Candida is shown as % killing. Neutrophils were treated with or without NADPH 
inhibitor diphenyleneiodonium (DPI, 10 µM) for 30 min before addition of opsonized yeasts (D). DPI was left in the culture over the entire period. n = 7–8 pooled from 
three independent experiments in panels (B,c); and n = 3 in panel (D). Data are presented as mean ± SD. *p < 0.05; ***p < 0.005; n.s., not significant, as analyzed 
by Mann–Whitney test. See also Figure S1 in Supplementary Material.
FigUre 1 | Opsonized Candida upregulates cytosolic gal3 expression in neutrophils. Bone marrow neutrophils were stimulated with opsonized Candida 
SC5314 (a–c) or GFP+ OG1 (D,e) for 5 or 15 min. Zero minutes represent unstimulated cell controls incubated in serum-containing medium for 15 min. (a) Cells 
were cytospun, permeabilized, and stained for gal3 (red) and nucleus (blue) before confocal microscopic analysis for gal3 expression. DIC, differential interference 
contrast. (B,c) Neutrophils were stained with rat anti-gal3 and PE-goat anti-rat antibodies, fixed in 4% PFA, permeabilized, and then stained with Alexa 647-rat 
anti-gal3 antibody. The % of cells expressing cytosolic gal3+ (B) and surface gal3+ (c) in total cell population are shown in upper panels. The levels of cytosolic (B) 
and surface gal3 (c) expression are shown as mean fluorescence intensity (MFI) in lower panels. Data are presented as mean ± SD. *p < 0.05, as analyzed by 
Mann–Whitney test. n = 3. (D,e) Neutrophils were allowed to ingest GFP+ OG1 Candida (green) and stained for gal3 (red) and nucleus (blue) before subjecting to 
fluorescence microscopic analysis. (D) The intensity of fluorochromes along the white arrow in the merged image is shown in the histogram on the right. (e) The % 
of gal3+ area (red) that is not overlapped with Candida (green) in the whole gal3+ area (red) (180,760 µm2 in average) at 5 and 15 min after encounter was analyzed 
by Metamorph software. Each dot represents one photo image. n = 5.
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and 85.9 ± 4.6% of the intracellular gal3 at 5 and 15 min time 
points, respectively, did not colocalize with opsonized Candida 
(Figures 1D,E). By tracking the movement of cytosolic gal3 in 
neutrophils upon encountering GFP-expressing Candida, we 
found that gal3 moved toward engulfed Candida (Figure S1 in 
Supplementary Material). At the point when gal3 was closest 
to Candida (7.56 min), it still did not associate with the organ-
ism (Figure S1 and Video 1 in Supplementary Material). These 
FigUre 3 | gal3 negatively regulates complement receptor 3 (cr3)-mediated killing of Candida by neutrophils. Neutrophils isolated from WT, gal3−/−, 
Itgam−/−, gal3−/−Itgam−/− mice were allowed to ingest opsonized Candida yeasts. (a,D) The level of reactive oxygen species (ROS) production is shown as mean 
fluorescence intensity (MFI) of oxidized DCF fluorescence. n = 3 in panel (a); n = 4 in panel (D). Experiment was performed twice. (B,e) The ability of neutrophils to 
kill opsonized Candida is shown as % killing. n = 3 in panel (B); and n = 4 in panel (e). Experiment was performed twice. Data are presented as mean ± SD. 
*p < 0.05; n.s., not significant, as analyzed by Mann–Whitney test. (c) Confocal fluorescence microscopic analysis to localize CR3 (red) and Candida OG1 (green). 
(F) Gal3 expression in Itgam−/− and WT neutrophils stimulated with opsonized Candida (Ops. Ca) was detected by Western blot. β-actin was used as a loading 
control. The numbers below the gel denote the relative intensity of gal3. Experiment was performed three times. (g,h) Confocal microscopy analysis to localize gal3 
(red) and CR3 (green). The intensity of different fluorochromes along the white arrow in the merged (c) and Gal3/CR3 (h) images is shown in the histogram on the 
right. (g) Metamorph software was employed to determine the percentages of non-localization between gal3 and CR3 in the whole gal3 area in image in panel (h) 
(56,444 µm2 in average). Each dot represents one photo. n = 4.
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results together indicate that stimulation by opsonized Candida 
upregulates gal3 expression in neutrophils and that intracellular 
gal3 does not bind to the engulfed organism.
gal3 negatively regulates complement 
receptor 3 (cr3) Downstream  
rOs-Dependent Killing of Candida  
in neutrophils
To unravel the role of upregulated gal3 in neutrophils, gal3+/+ and 
gal3−/− neutrophils were allowed to ingest opsonized Candida, 
and the subsequent cellular response was assessed. We found that 
gal3−/− neutrophils produced higher levels of ROS than gal3+/+ 
cells (Figure 2A). While gal3−/− and gal3+/+ cells were comparable 
in their abilities to engulf Candida (Figure 2B), gal3−/− neutro-
phils killed ingested Candida more efficiently than gal3+/+ cells 
(Figure  2C). Moreover, suppressing ROS completely abolished 
killing of ingested Candida yeasts by both gal3+/+ and gal3−/− 
neutrophils (Figure 2D). These results indicate that both gal3+/+ 
and gal3−/− neutrophils kill ingested Candida through a ROS-
dependent mechanism and that gal3 suppresses neutrophil fun-
gicidal activity through inhibiting ROS production. Interestingly, 
CR3-deficient (Itgam−/−) neutrophils were significantly less 
efficient in producing ROS (Figure 3A) and killing of opsonized 
Candida (Figure  3B) than WT cells, but such functions were 
not affected in dectin-1-deficient (clec7a−/−) neutrophils (Figures 
FigUre 4 | gal3 negatively regulates complement receptor 3 downstream syk-mediated neutrophil reactive oxygen species (rOs) response to 
Candida. Gal3+/+ (WT), gal3−/−, and Itgam−/− neutrophils were stimulated with opsonized Candida (Ops. Ca). (a) Cell lysates were collected at different time points 
after stimulation and subjected to Western blot analysis with anti-p-Syk antibody. β-actin was used as a loading control. (B) WT cells were pretreated with 2, 10, and 
50 µM of Syk inhibitor before stimulation. The levels of ROS produced by neutrophils at 20 min after stimulation were analyzed by flow cytometry. Relative ROS 
production was calculated by dividing mean fluorescence intensity of oxidized DCF fluorescence in Candida-stimulated cells by that in untreated cells. n = 6 as 
pooled from two independent experiments. (c) Cell lysates were collected at different time points after stimulation and subjected to Western blot analysis with 
anti-p-Syk, -Syk, or -p-p40phox antibodies. β-actin was used as a loading control. Relative intensity of p-Syk (n = 5) and p-p40phox (n = 2) at different time points are 
shown in the right panel. Data are presented as mean ± SEM. *p < 0.05, ***p < 0.005, as analyzed by Mann–Whitney test. (D) Whole cell lysates (WCL) were 
immunoprecipitated with anti-gal3 (IP: Gal3, upper panel) and anti-Syk (IP: Syk, lower panel) antibodies. Precipitates were subjected to Western blot analysis with 
anti-Syk and anti-gal3 antibodies. Experiments were performed three times. Data from one representative experiment are shown. (e) Confocal microscopy image of 
gal3 (red) and Syk (green) in neutrophils after stimulation by Candida. The intensity of different fluorochromes along the white arrow in the merged image is shown in 
the histogram on the right. See also Figure S1 in Supplementary Material.
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S2A,B in Supplementary Material). Immunofluorescence staining 
revealed that CR3 congregated around but did not colocalize with 
engulfed Candida (Figure 3C). Thus, it appears that ROS produc-
tion as a result of CR3 engagement is responsible for neutrophil 
fungicidal activity. In addition, gal3 deficiency promoted the 
abilities of dectin-1-deficient neutrophils to produce ROS (Figure 
S2C in Supplementary Material) and kill Candida (Figure S2D in 
Supplementary Material), whereas the presence or absence of gal3 
did not make any difference in ROS production (Figure 3D) and 
the ability to kill Candida by Itgam−/− cells (Figure 3E). It reveals 
that the suppressive effect of gal3 on neutrophil anti-Candida 
function is through CR3. It is worth noting that gal3 expression 
increased by twofold in Itgam−/− neutrophils after stimulation 
by opsonized Candida compared to that without stimulation 
(Figure 3F), revealing that gal3 upregulation is independent of 
CR3. Moreover, we found that majority (>72%) of the intracel-
lular gal3 in the cell population we tracked did not colocalize with 
CR3 (Figures 3G,H). These results together suggest that although 
neutrophil production of ROS is through CR3 engagement with 
Candida, gal3 does not directly interact with CR3.
FigUre 5 | gal3 regulates renal macrophage activation, monocytes, and dendritic cell recruitment in systemic Candida infection. Gal3+/+ and 
gal3−/− mice were infected intravenously with 5 × 105 of Candida. Kidneys were collected from infected mice at 18 and 48 h after infection. Renal infiltrating cells 
were isolated and stained for lineage specific markers as indicated. Total number of renal infiltrating cells (CD45+ cells) (a), the percentages and numbers of 
neutrophils (CD45+Ly6G+) (B), macrophages (Mφ, CD45+Ly6G−MHCII+F4/80+) (c), monocytes (CD45+Ly6G−MHCII−F4/80+) (D), and dendritic cells 
(CD45+Ly6G−MHCII+F4/80−) (e) in the kidney are shown. The levels of MHC class II expression on macrophages are shown as mean fluorescence intensity 
(c). n = 3. Data are presented as mean ± SD. *p < 0.05, ***p < 0.005, n.s., not significant, as analyzed by Mann–Whitney test.
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gal3 Physically interacts with syk and 
Downregulates cr3 Downstream  
syk-Mediated rOs Production
It is reported that CR3 engagement activates neutrophil killing 
of Candida through Syk signaling (31). Our data showed that 
the levels of pSyk in CR3-deficient neutrophils were completely 
abolished after stimulation (Figure  4A) while that in dectin-
1-deficient cells were comparable to WT cells (Figure S2E in 
Supplementary Material). Treatment with Syk inhibitor Bay 
61-3606 dose-dependently reduced neutrophil ROS production 
(Figure 4B). Importantly, the levels of pSyk and p-p40phox were 
significantly higher in gal3−/− than in gal3+/+ neutrophils after 
stimulation (Figure  4C). Reciprocal co-immunoprecipitation 
(Figure  4D) and immunofluorescence staining (Figure  4E) 
revealed that gal3 directly interacted with Syk after stimulation. 
Therefore, ROS production by neutrophils in response to 
opsonized Candida is Syk-dependent and gal3, by modulating 
Syk activation, regulates CR3 downstream signaling pathway(s) 
leading to ROS production.
gal3 Deficiency enhances the Fungicidal 
activity of renal infiltrating neutrophils
Previous studies revealed the role of gal3 in cell recruitment 
in  vivo (32, 33). To address whether gal3 also regulates cell 
infiltration in systemic candidiasis, we analyzed renal infiltrat-
ing neutrophils (CD45+Ly6G+), macrophages (CD45+Ly6G−M
HCII+F4/80+), monocytes (CD45+Ly6G−MHCII−F4/80+), and 
dendritic cell (CD45+Ly6G−MHCII+F4/80−) populations (34). 
The results showed that gal3 deficiency did not affect the recruit-
ment of neither neutrophils nor macrophages (Figures 5A–C). 
FigUre 6 | gal3 deficiency enhances infiltrating neutrophil anti-Candida functions. Gal3+/+ and gal3−/− mice were infected intravenously with 5 × 105 of 
Candida. (a) Blood was collected from naïve mice (0) or mice at 18 h and 48 h after infection. The levels of CD11b expression on CD45+CD11b+Ly6G+ peripheral 
blood neutrophils are presented as mean fluorescence intensity (MFI). n = 3. (B,c) CD45+CD11b+Ly6G+ cells were sorted from total infiltrating cells in the kidney at 
18 h after infection. The levels of reactive oxygen species (ROS) production (B) and their ability to kill (c) were determined. n = 3. Data are presented as mean ± SD. 
*p < 0.05, as analyzed by Mann–Whitney test.
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Gal3 deficiency, however, reduced monocyte (Figure 5D; Figure 
S4A in Supplementary Material) but enhanced dendritic cell 
(Figure  5E; Figure S4A in Supplementary Material) infiltra-
tion. In addition, the levels of chemokines were not different 
between gal3−/− and gal3+/+ mice after infection (Figure S3 in 
Supplementary Material). Interestingly, we found that renal 
infiltrating macrophages in gal3−/− mice expressed higher levels 
of MHC II (Figure 5C), iNOS, and lower CD206 than in gal3+/+ 
mice (Figure S4B in Supplementary Material).
Peripheral blood neutrophils from infected gal3−/− were 
compared to those from gal3+/+ mice for the levels of activation 
marker CD11b (35). Results in Figure 6A showed that CD11b 
on neutrophils from gal3−/− mice were significantly higher than 
cells from gal3+/+ mice after infection (Figure  6A). Moreover, 
renal infiltrating neutrophils of infected gal3−/− mice produced 
significantly higher amount of ROS (Figure 6B) and their abil-
ity to kill Candida (Figure 6C) was higher than cells of gal3+/+ 
mice. These results demonstrated that gal3 negatively regulates 
neutrophil functions not only in vitro but also in vivo.
Gal3−/− Mice are More resistant to 
systemic Candida infection
Consistent with higher neutrophil fungicidal functions, gal3−/− 
mice had better survival (Figure 7A) and lower fungal burdens 
in kidneys and brain (Figure  7B) than gal3+/+ mice when sys-
temically infected with Candida. While gal3+/+ mice sustained 
multiple abscesses in the kidney with their kidney weights being 
about 2.3-fold of that of uninfected mice, gal3−/− mice exhibited 
only minimal gross renal pathology and relatively less change in 
kidney weights (Figure 7C). The creatinine and blood urea nitro-
gen levels were also significantly lower in gal3−/− mice than in 
gal3+/+ mice (Figure 7D). Both gal3+/+ and gal3−/− mice exhibited 
chronic-active nephritis and pyelonephritis with inflammatory 
infiltrates on day 2 after infection. Starting on day 3, nephritis 
became severe in gal3+/+ mice, but remained minimal/slight in 
gal3−/− mice (Figure  7E), indicating that severe inflammation 
and tissue damage occurred to gal3+/+ but not to gal3−/− mice. 
Additionally, while hyphal/pseudohyphal forms of Candida were 
found in both infected gal3+/+ and gal3−/− mice on 18  h after 
infection, these forms increased and persisted in gal3+/+ mice, but 
became almost completely absent in gal3−/− mice by 3 days after 
infection (Figure S5 in Supplementary Material). These results 
together show that gal3 deficiency ameliorates systemic candidi-
asis by reducing fungal burdens, renal pathology, and mortality.
neutrophil intrinsic gal3 suppresses host 
Defense against Candida
Adoptive transfer experiments were performed to investigate 
whether gal3 regulates neutrophil functions in  vivo is a cell 
intrinsic event. We found that adoptively transferred gal3−/− neu-
trophils cleared Candida infection more efficiently than gal3+/+ 
neutrophils whether the recipient mice were gal3+/+ (Figure 8A) 
or gal3−/− (Figure  8B). Transfer of neutrophils from littermate 
donors also demonstrated the suppressive effect of gal3 on neutro-
phils in clearing Candida (Figure 8C). When neutrophil cytosolic 
factor 1-deficient (ncf-1−/−) mice were used as recipients, transfer 
of gal3−/− neutrophils also resulted in significantly less fungal 
burdens than transfer of gal3+/+ cells (Figure  8D). The results 
confirm that it is ROS produced by transferred neutrophils but 
not that by cells in the recipient mice that mediates host defense 
against Candida. Taken together, these results indicate that cell 
intrinsic gal3 regulates neutrophil anti-Candida function.
gal3 negatively regulates Primary human 
neutrophil rOs response to Opsonized 
Candida
Human neutrophils were like mouse neutrophils (Figure  1A) 
constitutively expressed gal3 in the cytosol but not on the surface 
(Figure  9A). Surface gal3 became detectable as early as 5  min 
after encountering opsonized Candida (Figure 9A). Interestingly, 
silencing Lgals3 in primary human neutrophils by siRNA sig-
nificantly enhanced ROS production (Figure  9B). Treatment 
with gal3 inhibitor TD139, a derivative of thiodigalactoside, 
augmented human neutrophil ROS production (Figure  9C) 
and reduced fungal burden in mice with systemic candidiasis 
(Figure  9D). These results demonstrate that gal3 is a negative 
regulator of human neutrophil ROS response and point to the 
possibility of employing TD139 as a treatment strategy to restore 
neutrophil functions against Candida infection.
FigUre 7 | gal3 deficiency ameliorates Candida infection. Gal3+/+ and gal3−/− mice were infected intravenously with 5 × 105 of Candida. Kidneys were 
collected from uninfected (naïve) and infected mice at different time points after infection (dpi). (a) The survival of infected mice was followed until day 10 after 
infection. n = 11. Data are pooled from three independent experiments. *p < 0.05, as analyzed by log-rank and Fisher’s exact test. (B) Fungal burden in the kidney 
is shown as Log10 CFU per gram of tissue. n = 6. Data are pooled from two independent experiments and presented as mean ± SD. (c) Kidneys were collected 
from uninfected and infected mice on different days after infection (dpi). Left, arrows point to abscess lesions; right, kidney weight. n = 6. Data are pooled from two 
independent experiments and presented as mean ± SD. (D) The levels of blood urea nitrogen and creatinine in mouse sera on day 2 after infection. n = 5. Data are 
pooled from two independent experiments. *p < 0.05; ***p < 0.005, as analyzed by Mann–Whitney test. (e) Kidneys were collected and fixed in formalin before H&E 
stain. The magnification is 200× for sections from naïve mice and mice at day 2 after infection and 40×, 200×, and 400× for sections from mice at day 3 after 
infection. Arrows point to inflammatory foci. n = 3. See also Figures S2 and S3 in Supplementary Material.
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The negative effect of gal3 on neutrophil 
rOs Production is generalizable to 
clinical C. albicans isolates
We tested C. albicans isolates from six patients with bloodstream 
candidiasis and showed that all six clinical isolates induced 
WT neutrophil ROS production (Figure  10A). Although the 
levels of ROS induced by different isolates varied, gal3 deficiency 
enhanced its production (Figure 10A). Isolates CL 15-1, CL 03-1, 
and CA 03-1, like SC5314, were more susceptible to killing by 
gal3−/− neutrophils than by gal3+/+ neutrophils (Figure  10B), 
while isolates CL 10-1, CA 09-1, and CA 01-1 were highly and 
equally susceptible (>90%) to killing by both gal3−/− and gal3+/+ 
neutrophils (Figure 10B). Consistent with the observation about 
FigUre 8 | adoptive transfer of gal3−/− neutrophils reduces fungal 
burden in recipient mice. Bone marrow neutrophils were collected from 
gal3+/+ and gal3−/− mice (a,B,D) or gal3−/− mice and their littermates (c). Five 
million cells were adoptively transferred into gal3+/+ (a,c), gal3−/− (B), and 
ncf-1−/− (D) recipients separately. Recipient mice were infected with 5 × 105 
(a–c) or 1 × 103 (D) of Candida yeast cells 1 h later. Fungal burdens in 
kidneys from recipient mice on 2 days after infection are shown as Log10 
(CFU per gram of kidney). n = 6 pooled from two independent experiments in 
panel (a); n = 3 in panel (B); n = 5 in panel (c); and n = 3 in panel (D). 
*p < 0.05; ***p < 0.005, as analyzed by Mann–Whitney test.
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the role of gal3 in systemic SC5314 infection, gal3−/− mice were 
more efficient than gal3+/+ mice in clearing CA 03-1 infection 
(Figure 10C) and had better survival (Figure 10D). Thus, gal3 
negatively regulates neutrophil ROS production in response to 
not only SC5314 but also other clinical isolates and the negative 
effect of gal3 on neutrophil killing is more pronounced on other-
wise “hard-to-kill” isolates.
DiscUssiOn
In this study, we show that gal3 serves as a negative regulator 
of human and mouse neutrophil anti-Candida functions. Gal3 is 
expressed in the cytosol of both unstimulated human and mouse 
neutrophils. Responding to opsonized Candida stimulation, gal3 
became detectable on the cell surface. While engulfed Candida 
is wrapped in phagosome (36), cytosolic gal3 does not directly 
contact the organism. Rather, it interacts with Syk and modulates 
its phosphorylation, through which it suppresses neutrophil 
anti-Candida function. Results of adoptive transfer experiments 
clearly demonstrates that cell intrinsic gal3 in neutrophils damp-
ens host resistance to candidiasis. The negative effect of gal3 
in primary human neutrophils is rescued by TD139 treatment 
and siRNA knockdown and demonstrable in neutrophil ROS 
response to clinical isolates of C. albicans. This study uncovers 
the immunomodulatory role of cell intrinsic gal3 in both human 
and mouse neutrophils and in host defense against systemic 
candidiasis in a mouse model.
Gal3 is proposed to be a biomarker for infectious disease (37). 
While the serum level of gal3 is low in healthy individuals, it is 
significantly elevated in patients with candidiasis compared to 
those with non-infectious inflammation (37). It appears that gal3 
remains largely intracellular in healthy homeostatic condition and 
is released into circulation in systemic Candida infection. Since 
recombinant gal3 enhances human neutrophil phagocytosis of 
Candida parapsilosis yeasts and C. albicans hyphae (14), released 
gal3 in the body may enhance uptake of Candida by neutrophils. 
Here, we addressed cytosolic gal3 in anti-Candida functions and 
found that both human and mouse neutrophils constitutively 
express cytosolic gal3 and it is redistributed and becomes detect-
able on the surface after stimulation. Thus it seems unlikely that 
gal3 participates in neutrophil recognition of Candida. Employing 
β-lactose (up to 50  mM), a cell-impermeable pan-galectin 
inhibitor, we observed that neutrophil ROS production is not 
affected by the inhibitor after stimulation by opsonized Candida 
(unpublished data). Treatment with TD139, a cell-permeable gal3 
inhibitor (F.-T. L., unpublished observation), however, increases 
neutrophil ROS production. Thus, it is cytosolic gal3 that nega-
tively regulates neutrophil ROS production. Since neutrophils are 
of primary importance in defense against systemic candidiasis, 
the negative role of cytosolic gal3 in neutrophil anti-Candida 
functions cannot be ignored.
Cytosolic gal3 has been shown to bind to Alix, a subunit of 
the endosomal sorting complex, thereby promoting intracellular 
trafficking and surface expression of epidermal growth factor 
(EGF)-receptor in keratinocytes and enhancing EGF-induced 
migration (7). Gal3 is also known to serve as a binding partner 
of activated K-Ras, through which it enhances PI3K and Raf-1 
activation (10). Gal3 binding to Bax protein in human thyroid 
carcinoma cells responding to apoptosis stimulus interferes with 
apoptosis (12). We show that cytosolic gal3 directly associates 
with Syk upon CR3 engagement. We reason that gal3 inhibits 
Syk phosphorylation through this interaction, thereby regulating 
a CR3 downstream signaling pathway. Syk being downstream of 
integrin engagement can be negatively regulated by E3 ligase Cbl 
resulting in degradation or by SH2 domain tyrosine phosphatase 
SHP-1 (38). Our data show that the levels of Syk protein in gal3+/+ 
and gal3−/− neutrophils remain unchanged after stimulation, sug-
gesting that Cbl is not involved in gal3-mediated inhibition of 
Syk activation. It still awaits to be clarified whether gal3 regulates 
Syk through recruitment of SHP-1 or through other mechanisms.
Gal3 has been shown to modulate immune response to infec-
tions in different animal models. In pulmonary Streptococcus 
pneumonia infection, the number of infiltrating neutrophils 
in the lungs of gal3−/− is lower than in gal3+/+ mice (33). In 
experimental multiple sclerosis mouse model, gal3−/− mice 
infected with Theiler’s murine encephalomyelitis virus have 
reduced CCL2, CCL5, CCL8, and CXCL10 expression and lower 
number of infiltrating cells in the brain subventricular zone (32). 
Infected with Trypanosoma cruzi, gal3−/− mice exhibit higher 
FigUre 9 | reducing gal3 expression or activity enhances human neutrophil reactive oxygen species (rOs) response to opsonized Candida and 
host resistance to Candida infection. (a–c) Human neutrophils isolated from peripheral blood of healthy volunteers were allowed to ingest opsonized (in 5% 
human serum) Candida yeasts. (a) The % of cells expressing cytosolic gal3+ or surface gal3+ in total cells. (B,c) Cells were transfected with gal3 (Gal3 si) or 
scrambled (Scramble) siRNA (B) or pretreated with mock (0.5% DMSO) or 250 µM of TD139 for 4 h (c) before stimulation with opsonized Candida. The level of 
ROS production by neutrophils was analyzed by flow cytometry at 20 min after stimulation. Relative ROS production was calculated by dividing the mean 
fluorescence intensity (MFI) of cells treated with Gal3 siRNA TD139 and by that treated with scrambled siRNA and in DMSO, respectively. The levels of gal3 protein 
in cells transfected with gal3 or scrambled siRNA were detected by Western blot to determine the efficiency of gal3 siRNA knockdown. β-actin was used as a 
loading control. The numbers below the gel denote the relative intensity of gal3. (D) Gal3+/+ mice were infected with 5 × 105 of Candida yeast cells intravenously. 
After 30 min, infected mice were injected with 1.5% DMSO (DMSO) or 300 µg of TD139 in 200 µl of RPMI medium intraperitoneally. Fungal burdens in kidneys from 
infected mice on 2 days after infection are shown as Log10 (CFU per gram of kidney) n = 4 in panel (B); n = 7 in panel (c); and n = 8 in panel (D). *p < 0.05; 
***p < 0.005, as analyzed by Mann–Whitney test.
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levels of parasitemia but have reduced cellular infiltration and 
tissue damage in the heart (39). Systemic infection by C. albicans 
results in inflammation-induced renal pathology leading to 
death while Ccr1−/− or Ifnar1−/− mice have reduced number of 
renal infiltrating cells and develop less severe renal pathology and 
better survival (40, 41), suggesting that neutrophil infiltration in 
systemic candidiasis denotes poor prognosis. Although studies of 
bacterial and parasitic infections demonstrate that the presence 
of gal3 affects neutrophil infiltration, we observed in this study 
that while the expression of neutrophil-attracting chemokines 
and renal neutrophil infiltration are comparable in gal3+/+ and 
gal3−/− mice after systemic Candida infection, gal3−/− mice have 
less renal pathology and better survival than gal3+/+ mice. Renal 
infiltrating neutrophils from gal3−/− mice produce higher level of 
ROS and kill Candida more efficiently. Thus, gal3 functions to 
inhibit neutrophil ROS production and the ability of neutrophils 
to kill Candida in systemic candidiasis rather than positively 
modulate cellular infiltration like that in bacterial and parasitic 
infections.
Innate cells other than neutrophils are also known to 
be involved in protecting the host from Candida infection. 
Depleting monocyte/macrophage by clodronate-containing 
FigUre 10 | The effect of gal3 on neutrophil response to Candida albicans clinical isolates. (a,B) Bone marrow neutrophils isolated from gal3+/+ and 
gal3−/− mice were allowed to ingest opsonized C. albicans clinical isolates CL 10-1, CA 09-1, CL 15-1, CA 01-1, CL 03-1, CA 03-1, and SC 5314. (a) The levels of 
reactive oxygen species (ROS) production are shown as mean fluorescence intensity (MFI) of oxidized DCF fluorescence. n = 4. (B) The abilities of neutrophils to kill 
opsonized Candida are shown as % killing. n = 4. Data are presented as mean ± SD. *p < 0.05, as analyzed by Mann–Whitney test. (c,D) Gal3+/+ and gal3−/− mice 
were infected intravenously with 1 × 106 of clinical isolate CA 03-1. (c) Fungal burdens in kidneys on day 2 after infection are presented as Log10 (CFU per gram of 
kidney). Gal3+/+, n = 4; and gal3−/−, n = 3. *p < 0.05, as analyzed by Mann–Whitney test. (D) The survival of infected mice was followed until day 10 after infection. 
Gal3+/+, n = 6; and gal3−/−, n = 5. *p < 0.05, as analyzed by log-rank and Fisher’s exact test.
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liposomes abolishes host resistance to systemic candidiasis (42). 
Depleting CCR2+ cells interrupts monocyte infiltration and 
increases fungal burdens in kidney, brain, and spleen during 
early phase of Candida infection (43). Reduced number of renal 
infiltrating macrophages in infected CX3CR1-deficient mice 
significantly exacerbates systemic candidiasis (34). Moreover, E3 
ubiquitin ligase CBLB protein negatively regulates macrophage 
and dendritic cell anti-Candida functions with Cblb−/− mice 
more resistant to Candida infection (44). Knocking out Syk 
in dendritic cells with CD11c promoter-driven Syk-deletion 
demonstrates that dendritic cells contribute to clearance of 
Candida through production of IL-23 which is important to NK 
cell secretion of GM-CSF (45). NK cell-derived GM-CSF pro-
motes neutrophil ROS production and fungicidal activity (46). 
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We discovered that in addition to regulation of neutrophil ROS 
production, endogenous gal3 was also involved in macrophage 
activation, monocyte, and dendritic cell recruitment to kidneys 
in systemic candidiasis. Consistent with previous findings (47, 
48), we found that gal3 plays a positive role in activation of 
M2 macrophage marked by lower MHC II and higher CD206 
expression. Moreover, the negative effect of gal3 is abolished by 
depleting either neutrophils or macrophages (Figures S6A,B in 
Supplementary Material). These results show that gal3 is involved 
not only in neutrophil but also other myeloid cell anti-Candida 
immune response. While we delineated the mechanism of how 
gal3 regulates neutrophil ROS production through suppression 
of Syk activation, the mechanism of how gal3 regulates mac-
rophages and dendritic cells in systemic candidiasis warrants 
further study.
While our study reveals the negative role of gal3 in systemic 
infection with Candida (5 × 105 CFU), Linden et al. reported an 
opposite effect (49). In their study, gal3+/+ mice infected with low 
lethal dose of Candida (1.0 × 105 CFU) have fewer abscesses in 
the kidneys, lower fungal burdens and better survival than gal3−/− 
mice. Exaggerated inflammatory infiltration and uncontrolled 
inflammatory responses were attributed to higher mortality in 
gal3−/− mice. Previous study employing Ifnar1−/− mice showed 
opposite effects of type I interferon in host responses to high 
lethal (5.0 × 105 CFU), low lethal (1.0 × 105 CFU), and sublethal 
(5.0 × 104 CFU) doses of Candida challenge (41). We speculate 
that different sizes of inoculum, different commensal flora in the 
mice resulting from different housing conditions, as well as the 
difference in the embryonic stem cells (WW6 ES cells vs. D3 ES 
cells) employed and the backcross strategy may account for our 
opposite observations. However, our adoptive transfer experi-
ments showing that transferred gal3−/− neutrophils clear Candida 
more efficiently in recipient mice than gal3+/+ neutrophils support 
our conclusion that cell intrinsic gal3 negatively regulates host 
defense against systemic candidiasis.
Our results show that gal3 regulates both human and mouse 
neutrophil ROS production and that the efficiency of neutrophils 
to kill Candida varies depending on the isolates they encountered. 
Gal3 deficiency enhances the ability of mouse neutrophils to kill 
when encountering “hard-to-kill” Candida. Based on galectin 
CRD binding to β-galactoside, Nilsson and colleagues developed 
a novel gal3 antagonist, TD139 (50). While TD139 binds to gal1, 
3 and 7, its binding affinity to gal3 is much higher than binding 
to gal7 and gal1 (27). Since TD139 can get inside the cell, our 
results showing this compound inhibits neutrophil ROS produc-
tion suggest that TD139 functions intracellularly to interfere gal3 
and Syk association. Treatment with TD139 has been reported to 
reduce disease severity in animal models of idiopathic pulmonary 
fibrosis (51), Concanavalin A-induced hepatitis (52), and type 1 
diabetes (53). These studies demonstrated a potential treatment 
strategy for using TD139 in diseases where gal3 contributes 
positively to pathogenesis. Phase I clinical trial has demonstrated 
that TD139 is safe and tolerable when used in healthy volunteers 
(http://ClinicalTrials.gov identifier, NCT02257177). Thus, using 
TD139 to block the activity of gal3 is a viable option for enhancing 
neutrophil killing of Candida possibly when used in combination 
with antifungal drug treatment.
In summary, this study shows that the dynamics of gal3 in 
cytosol changes after neutrophils encountering Candida. Gal3 
which physically interacts with Syk negatively affects CR3 
downstream Syk phosphorylation and thus negatively regulates 
Syk-mediated ROS production. We also demonstrate in adop-
tive transfer experiments that cell intrinsic gal3 in neutrophils 
dampens host defense against candidiasis. The effect of gal3 
in neutrophil interaction with C. albicans is generalizable to 
“hard-to-kill” clinical isolates. This study uncovers the new 
role of cytosolic gal3 in binding to Syk and in modulating CR3 
downstream signal pathway in response to Candida. Importantly, 
treatment with antagonist TD139 and silencing gal3 expression in 
human neutrophils enhances neutrophil anti-Candida function. 
Our study points to the possibility of targeting gal3 as a potential 
therapeutic strategy for controlling systemic candidiasis.
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